SBIR-STTR Award

Enhanced DNA Microarray Performance With Gapped Probes
Award last edited on: 11/29/05

Sponsored Program
SBIR
Awarding Agency
NIH : NCHGR
Total Award Amount
$966,761
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
John S Oliver

Company Information

Genespectrum Inc

49 Pavillion Avenue
Providence, RI 02905
   (401) 863-2844
   N/A
   N/A
Location: Single
Congr. District: 01
County: Providence

Phase I

Contract Number: 1R43HG002181-01A1
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2001
Phase I Amount
$176,075
The goal of this project is to develop a more powerful and robust system for the sequencing and analysis of DNA by hybridization to microarrays. Our conceptually novel approach is based on a new probe design and sequence reconstruction algorithm which has been demonstrated by computational modeling to provide higher information density on a DNA hybridization chip. The Human Genome Project is providing unique insight into a wide range of biological phenomena and diseases. The biotechnology sector and end users of biotechnology products will drive a multibillion dollarmarket for DNA-based diagnostics and research tools. By the year 2005 it is expected that diagnostic tests based on DNA probes will be a $6 billion market. A significant portion of this market will use DNA microchip arrays. Our method will provide a superior method for analyzing DNA for medical diagnostics and for de novo sequencing. PROPOSED COMMERCIAL Improved DNA microarrays will be useful in clinical diagnostics, drug discovery expression profiling, as well as de novo DNA sequencing.

Phase II

Contract Number: 2R44HG002181-02A1
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2004
(last award dollars: 2005)
Phase II Amount
$790,686

The goal of the proposed research is to develop a method for significantly improving the performance of sequencing by hybridization (SBH), thus decreasing the cost and increasing the speed of sequencing DNA. If successful, the technology that GeneSpectrum Inc. is developing will reduce the cost of such sequencing by 100 fold. The limitations of current DNA sequencing technology and the growing appetite for DNA sequence information define a need for a rapid, inexpensive method for DNA sequence determination, particularly in applications to human health. Sequencing by hybridization was proposed as an efficient method for sequencing DNA in the late 1980s and early 1990s. The method proved to be inefficient and was essentially abandoned. We have discovered a novel approach to the design and interpretation of arrays that provides a large increase in the amount of information that can be extracted from the array and that will make SBH a viable technique. Our method relies on arrays of oligonucleotide probes that contain natural bases and universal bases. In the context of this proposal universal bases are defined as nucleotide analogs that, when incorporated into DNA, hybridize equally well with all four of the cognate bases. The universal bases are used to arrange the natural bases into patterns in the oligonucleotide probes. Arrays of these patterned oligonucleotides allow us to use unique algorithms that result in highly efficient sequence reconstruction. In the last two years, we have investigated the ability of several molecules to function as the universal base in our patterned probes. We have recently discovered a method to make surrogates of universal bases by using specific mixtures of natural bases, which we refer to as "semi-degenerate" bases. The result is the delineation of a method to form patterned probes that can be tested and used immediately. The objective of the project proposed here is to demonstrate that semi-degenerate bases will function in arrayed, patterned probes as universal bases.

Thesaurus Terms:
method development, microarray technology, nucleic acid hybridization, nucleic acid probe, nucleic acid sequence, technology /technique development computer program /software, genetic screening, nucleobase, nucleobase analog biotechnology